Senior Pharmacovigilance Director, Oncology

GlaxoSmithKline plc; Melbourne; Hybrid; AUD 155,000 - 258,000; Full time

Job summary

GSK is seeking a senior Pharmacovigilance professional to lead safety evaluation and risk management for Classic & Established Products. The role requires expertise in clinical datasets, regulatory submissions, and cross-functional leadership to drive safety governance and issue resolution.

The position emphasizes strategic risk management, interactions with health authorities, and readiness for inspections, with hybrid work in Poland as indicated by the posted content.

Qualifications

• Relevant degree qualification.
• Experience in the pharmaceutical or biotechnology industry in Pharmacovigilance, Drug Safety, Clinical Development, or a related field.
• Pharmacovigilance experience in safety evaluation and risk management involving clinical-development or post-marketing products.
• Knowledge of international pharmacovigilance requirements and frameworks, including ICH guidance, Good Pharmacovigilance Practices modules, or CIOMS guidance.
• Experience working in a cross-functional matrix organization.

Responsibilities

• Leads Pharmacovigilance and Risk Management Planning and develops strategy for evaluating issues in the clinical matrix.
• Leads safety component of global regulatory submissions.
• Drives safety governance and cross-functional teams to address safety issues.

Skills

Digital Fluency

Enterprise Leadership

Influencing Without Authority

Pharmacovigilance

Presentation Techniques

Education

MD / MBBS / MBChB or equivalent

Residency or specialty training

Health sciences / nursing / pharmacy degree options

Job description

GSK is seeking a senior Pharmacovigilance professional to lead safety evaluation and risk management for Classic & Established Products. The role requires expertise in clinical datasets, regulatory submissions, and cross-functional leadership to drive safety governance and issue resolution.

The position emphasizes strategic risk management, interactions with health authorities, and readiness for inspections, with hybrid work in Poland as indicated by the posted content.